Contact: Arturo Araiza
Production Training Supervisor
47900 Bayside Parkway
Fremont, CA 94538-6515
ETP Funding $750,000
Located across from the new Tesla Motors plant in Fremont, Boston Scientific is part of the growing manufacturing companies along the interstate 880 corridor. The company is a worldwide developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties including cardiology, urology, gynecology, and neurovascular intervention. Boston Scientific employs 2,252 workers at its three California manufacturing plants in San Jose, Fremont, and Valencia and will 700 frontline manufacturing employees.
Boston products manufactured in California include a broad line of imaging catheters (coated and uncoated) and micro-delivery stents to treat diseases of the human vascular and neurovascular systems. The company’s flagship products include NequroForm® and Wingspan® Stent Systems to treat brain and/or wide neck aneurysms, each under a Humanitarian Device Exemption approval granted by the Food & Drug Administration. Other products include: Taxus Express Coronary Stent System®, AID Automatic Implantable Defibrillator®, and the Ventak Implantable Cardioverter Defibrillator®. Boston Scientific invested over $900 million in research and development in 2010 resulting in the creation of an extensive pipeline of over 150 new products and is committed to retaining a manufacturing workforce in California.
The manufacture of its products is a highly exacting and complex process due in part to strict regulatory requirements imposed by the Food and Drug Administration (FDA) and other foreign regulatory agencies where products are sold. To be successful, Boston Scientific must have an experienced, well trained workforce that can understand and follow specific quality protocols and manufacturing procedures, while at the same time work efficiently and contribute to the high work standards required by the biotech industry.
All told, Training is targeted to meet the need for an expanded and more skilled manufacturing workforce; to foster job retention in industries threatened by out-of-state competition; and, for promoting the California biotech manufacturing workforce.